CELL INTELLIGENCE · 肿瘤细胞治疗研究

免疫效应细胞相关肠炎的组织学谱系与 T 细胞克隆性特征

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

Idecabtagene Vicleucel 后 100 天内的感染及其对复发/难治性多发性骨髓瘤生存的影响：一项 CIBMTR 分析

Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.

将 B 细胞与浆细胞靶向从肿瘤学转化至自身免疫：模式、定量桥接与开发路线图

Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap.

CAR 疗法在肿瘤与自身免疫领域的演进：机制见解与治疗创新

The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations.

多发性骨髓瘤与拟态：CAR-T 细胞治疗和抗 CD38 单克隆抗体治疗后患者的胃肠道组织学表现

Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38

氟达拉滨清淋暴露与复发/难治性多发性骨髓瘤患者接受 Idecabtagene-Vicleucel 后毒性相关：来自美国骨髓瘤免疫治疗联盟的真实世界经验

Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Ex

在该真实世界中接受 ide-cel 治疗的人群中，预测的 Flu 暴露是 CAR-T 毒性的独立预测因素。

用于 CAR-T 细胞治疗的一种新型分选细胞——分离 CD14(-)CD127(+) T 细胞用于 CAR-T 细胞制备

A new sort of cells for chimeric antigen receptor T-cell therapies-isolating CD14(-)CD127(+) T cells for chimeric antigen receptor T-cell manufacture.

我们开发了一种新的两步分离方法，用于从 PBMC 中富集 CD14⁻CD127⁺ T 细胞。

用于抗 CD19 与抗 BCMA 嵌合抗原受体（CAR）T 细胞治疗后早期神经毒性检测的新型神经认知测试工具：一项初步研究

Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy:

简短神经认知测试可切实用于 CAR-T 细胞治疗后 ICANS 的早期检测，预测哪些患者可能在最初 30 天内进展为 ICANS，并克服 ICE 评估工具的局限性。

血液系统恶性肿瘤的 CAR-T 细胞治疗：从基础与转化研究到临床实践的启示

Chimeric antigen receptor T-cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practice.

IL-18 分泌型多抗原靶向 CAR-T 细胞在免疫健全小鼠模型中清除抗原低表达骨髓瘤

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model.